Endothelial vasoactive mediators in young patients with minor heart anomalies

Endothelial vasoactive mediators in young patients with minor heart anomalies

Aim. To investigate regulatory vasoactive mediators – endothelin-1 (ET-1), 6-ketoprostaglandin F1α (6-keto-PGF1α), thromboxane В2 (TXВ2) – in young patients with minor heart anomalies (MHA) and non-differentiated connective tissue dysplasia (CTD). Material and methods. Fifty-three patients, 37 men a...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Yagoda, N. N. Gladkikh
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2007-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	minor heart anomalies endothelial dysfunction vasoactive mediators
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1251
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MINOR HEART ANOMALIES
by: E. V. Zemtsovskyi, et al.
Published: (2012-02-01)

Endothelial vasoactive function in children and adolescents with obesity and metabolic syndrome
by: V. V. Bekezin, et al.
Published: (2007-06-01)

Beyond the heart: a review exploring non-cardiovascular effects of vasoactive agents
by: Peng Lan, et al.
Published: (2025-07-01)

Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma
by: Josy Thomas, et al.
Published: (2024-11-01)

Vasoactive intestinal polypeptide level in gastroesophageal reflux disease before and after surgical treatment
by: Ye. I. Haidarzhi, et al.
Published: (2023-07-01)

Relation of the heart remodeling and endothelial dysfunction in chronic heart failure patients
by: Ch. A. Abdullaeva, et al.
Published: (2016-02-01)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01)

Chronic diarrhea related to neuroblastoma: the important role of vasoactive intestinal peptide in tumor pathology and survival
by: Meng-ying Cao, et al.
Published: (2025-03-01)

Diagnosis of Multiple Organ Dysfunction in Neonates with Hypoxic–Ischemic Encephalopathy: Vasoactive Inotropic Score, Renal Score, Fibrosis-5 Index and Lactate/Albumin Ratio
by: Başak Kaya, et al.
Published: (2024-12-01)

Impact of the implementation of vasoactive drug protocols on costs in the treatment of critically ill patients
by: Juana Benedí-González, et al.
Published: (2018-03-01)

Physical rehabilitation and endothelial dysfunction in coronary heart disease
by: V. A. Margazin, et al.
Published: (2006-02-01)

THE INFLUENCE OF CORONARY BYPASS ON ENDOTHELIAL AND ERECTILE DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: S. A. Pomeshkina, et al.
Published: (2015-01-01)

Influence of endothelial NO synthase gene polymorphisms on development and prognosis of chronic heart failure
by: N. F. Yakovleva, et al.
Published: (2008-10-01)

ENDOTHELIAL DYSFUNCTION AND ROLE NITRATES AND BETA-BLOCKERS IN ITS CORRECTION IN ISCHEMIC HEART DISEASE
by: A. N. Britov
Published: (2016-05-01)

Detecting age-related changes in faecal vasoactive intestinal polypeptide using a 3D-printed electrochemical immunosensor
by: Khalil K. Hussain, et al.
Published: (2025-10-01)

The Сontent of Some Humoral and Metabolic Vasoactive Factors in the Blood of the Cirrhotic Patients and Their Dependence on the Hepatopulmonary Syndrome Severity Degree
by: Abrahamovych M., et al.
Published: (2016-12-01)

Mediators of intracellular interactions and endothelial function in myxomatous mitral valve prolapse
by: A. V. Yagoda, et al.
Published: (2013-02-01)

Features of vasoactive substance regulation in chorionic villi in women with spontaneous abortion and active cytomegalovirus infection
by: I. A. Andrievskaya, et al.
Published: (2022-07-01)

ENDOTHELIAL DYSFUNCTION AND “OXIDATIVE STRESS” BY THE NONNSTABLE COURSE OF ISCHEMIC HEART DISEASE
by: A. E. Kratnov, et al.
Published: (2014-07-01)

Analysis of the heterogeneous treatment effect of vasoactive drug dosage and time on hospital mortality across different sepsis phenotypes: a retrospective cohort study
by: Jiacheng Shen, et al.
Published: (2025-05-01)

Endothelial dysfunction in heart failure with normal systolic function, and its correction with a metabolic agent, mildronate
by: V. P. Geychenko, et al.
Published: (2005-08-01)

Prognostic value of the vasoactive-inotropic score in predicting outcomes following LVAD implantation
by: Taylor Pickering, DO, et al.
Published: (2025-08-01)

Diagnostic assessment of endothelial function in metabolic syndrome and coronary heart disease
by: V. A. Nevzorova, et al.
Published: (2011-04-01)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-09-01)

Serum Vasoactive Intestinal Peptide as a Novel Biomarker for Low‐Voltage Areas in Patients With Atrial Fibrillation
by: Kotaro Nishino, et al.
Published: (2025-04-01)

Endothelial Microvascular Dysfunction and Its Relationship with Haptoglobin Levels in Patients with Different Phenotypes of Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2021-11-01)

Pharmacological correction of plasma redox potential and endothelial dysfunction in ischemic heart failure
by: O. P. Donetskaya, et al.
Published: (2012-02-01)

ENDOTHELIAL DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2016-01-01)

C1 inhibitor deficient hereditary angioedema is related to endothelial dysfunction in young adult and middle‐aged patients
by: Gokce Gul Atay Sensoy, et al.
Published: (2025-06-01)

Vasoactive intestinal peptide exerts therapeutic action by regulating PTEN in a model of Sjögren's disease
by: Yixi Li, et al.
Published: (2023-07-01)

DIAGNOSTIC SIGNIFICANCE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATIENTS WITH PRIMARY MITRAL VALVE PROLAPSE
by: A. V. Yagoda, et al.
Published: (2017-12-01)

Higher vasoactive usage despite hemodynamic goals is associated with higher mortality in acute myocardial infarction-related cardiogenic shock
by: Jorge A. Ortega-Hernández, et al.
Published: (2025-02-01)

Endothelial dysfunction and prognosis after coronary interventions in patients with coronary heart disease and arterial hypertension
by: M. V. Kazak, et al.
Published: (2011-10-01)

Endothelial dysfunction and dynamics of cytokine and C-reactive protein levels in chronic heart failure patients
by: A. P. Rebrov, et al.
Published: (2005-04-01)

Endothelial function in young men with essential hypertension
by: G. R. Yanovskaya, et al.
Published: (2004-06-01)

Endothelial dysfunction. Do we understand this term properly?
by: T. D. Vlasov, et al.
Published: (2020-05-01)

Basic therapy efficacy in children with pulmonary hypertension related to congenital heart defects: place of endothelial dysfunction and systemic inflammation markers
by: E. Yu. Emelyanchik, et al.
Published: (2016-10-01)

Antibody-mediated rejection in heart transplantation
by: V. S. Kvan, et al.
Published: (2022-01-01)

The level of vasoactive intestinal polypeptide in patients with hypothyroidism and impaired intestinal function, and its association with markers of visceral hypersensitivity
by: V.H. Mishchuk, et al.
Published: (2025-06-01)

White coat hypertension in non-differentiated connective tissue dysplasia: constitutional characteristics and endothelial-platelet dysfunction
by: N. N. Gladkikh, et al.
Published: (2007-04-01)